Direct costs of glaucoma: Relationship between cost and severity of the disease

Autores
Real, Juan Pablo; Lafuente, M. C.; Palma, Santiago Daniel; Tartara, Luis Ignacio
Año de publicación
2018
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
o estimate the direct medical costs associated with the management of patients with primary open-angle glaucoma and to compare the costs of patients according to the degree of severity. A longitudinal retrospective study was carried out using all patients with primary open-angle glaucoma that recorded follow-up from May 2010 to June 2013 at the Hospital Privado de Córdoba. We estimated the cost of the disease from the perspectives of the institution, with a bottom-up approach. Results: The three-year follow-up after treatment of 104 patients revealed that the average cost of care for a patient with primary open-angle glaucoma was US$2746 ± 1560. The first year of treatment was significantly more expensive than subsequent ones (US$1100–$810–$827). Cost was related to the degree of severity of glaucoma; patients in “Stage 0” had significantly lower costs than those in other groups (Kruskal–Wallis test, p < 0.01). This was a consequence of lower costs associated with medication and a lower percentage of patients undergoing surgery. The direct medical costs of a patient with primary open-angle glaucoma vary according to the severity of their disease and the year of treatment. We found that costs increased with disease severity, but decreased over time.
Fil: Real, Juan Pablo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica; Argentina
Fil: Lafuente, M. C.. Hospital Privado Centro Medico de Córdoba; Argentina
Fil: Palma, Santiago Daniel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica; Argentina
Fil: Tartara, Luis Ignacio. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica; Argentina
Materia
COST OF ILLNESS
GLAUCOMA
HEALTH EXPENDITURES
OBSERVATIONAL STUDIES AS TOPIC
SEVERITY OF ILLNESS INDEX
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/91908
Acceder
id CONICETDig_d7d8ca81110ec57414586086df07b499
oai_identifier_str oai:ri.conicet.gov.ar:11336/91908
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Direct costs of glaucoma: Relationship between cost and severity of the diseaseReal, Juan PabloLafuente, M. C.Palma, Santiago DanielTartara, Luis IgnacioCOST OF ILLNESSGLAUCOMAHEALTH EXPENDITURESOBSERVATIONAL STUDIES AS TOPICSEVERITY OF ILLNESS INDEXhttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3o estimate the direct medical costs associated with the management of patients with primary open-angle glaucoma and to compare the costs of patients according to the degree of severity. A longitudinal retrospective study was carried out using all patients with primary open-angle glaucoma that recorded follow-up from May 2010 to June 2013 at the Hospital Privado de Córdoba. We estimated the cost of the disease from the perspectives of the institution, with a bottom-up approach. Results: The three-year follow-up after treatment of 104 patients revealed that the average cost of care for a patient with primary open-angle glaucoma was US$2746 ± 1560. The first year of treatment was significantly more expensive than subsequent ones (US$1100–$810–$827). Cost was related to the degree of severity of glaucoma; patients in “Stage 0” had significantly lower costs than those in other groups (Kruskal–Wallis test, p < 0.01). This was a consequence of lower costs associated with medication and a lower percentage of patients undergoing surgery. The direct medical costs of a patient with primary open-angle glaucoma vary according to the severity of their disease and the year of treatment. We found that costs increased with disease severity, but decreased over time.Fil: Real, Juan Pablo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica; ArgentinaFil: Lafuente, M. C.. Hospital Privado Centro Medico de Córdoba; ArgentinaFil: Palma, Santiago Daniel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica; ArgentinaFil: Tartara, Luis Ignacio. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica; ArgentinaSAGE Publications Ltd2018-09-04info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/91908Real, Juan Pablo; Lafuente, M. C.; Palma, Santiago Daniel; Tartara, Luis Ignacio; Direct costs of glaucoma: Relationship between cost and severity of the disease; SAGE Publications Ltd; Chronic Illness; 4-9-2018; 1-91745-92061742-3953CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/http://journals.sagepub.com/doi/10.1177/1742395318803660info:eu-repo/semantics/altIdentifier/doi/10.1177/1742395318803660info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-10-22T12:03:53Zoai:ri.conicet.gov.ar:11336/91908instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-10-22 12:03:53.727CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Direct costs of glaucoma: Relationship between cost and severity of the disease
title Direct costs of glaucoma: Relationship between cost and severity of the disease
spellingShingle Direct costs of glaucoma: Relationship between cost and severity of the disease
Real, Juan Pablo
COST OF ILLNESS
GLAUCOMA
HEALTH EXPENDITURES
OBSERVATIONAL STUDIES AS TOPIC
SEVERITY OF ILLNESS INDEX
title_short Direct costs of glaucoma: Relationship between cost and severity of the disease
title_full Direct costs of glaucoma: Relationship between cost and severity of the disease
title_fullStr Direct costs of glaucoma: Relationship between cost and severity of the disease
title_full_unstemmed Direct costs of glaucoma: Relationship between cost and severity of the disease
title_sort Direct costs of glaucoma: Relationship between cost and severity of the disease
dc.creator.none.fl_str_mv Real, Juan Pablo
Lafuente, M. C.
Palma, Santiago Daniel
Tartara, Luis Ignacio
author Real, Juan Pablo
author_facet Real, Juan Pablo
Lafuente, M. C.
Palma, Santiago Daniel
Tartara, Luis Ignacio
author_role author
author2 Lafuente, M. C.
Palma, Santiago Daniel
Tartara, Luis Ignacio
author2_role author
author
author
dc.subject.none.fl_str_mv COST OF ILLNESS
GLAUCOMA
HEALTH EXPENDITURES
OBSERVATIONAL STUDIES AS TOPIC
SEVERITY OF ILLNESS INDEX
topic COST OF ILLNESS
GLAUCOMA
HEALTH EXPENDITURES
OBSERVATIONAL STUDIES AS TOPIC
SEVERITY OF ILLNESS INDEX
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.2
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv o estimate the direct medical costs associated with the management of patients with primary open-angle glaucoma and to compare the costs of patients according to the degree of severity. A longitudinal retrospective study was carried out using all patients with primary open-angle glaucoma that recorded follow-up from May 2010 to June 2013 at the Hospital Privado de Córdoba. We estimated the cost of the disease from the perspectives of the institution, with a bottom-up approach. Results: The three-year follow-up after treatment of 104 patients revealed that the average cost of care for a patient with primary open-angle glaucoma was US$2746 ± 1560. The first year of treatment was significantly more expensive than subsequent ones (US$1100–$810–$827). Cost was related to the degree of severity of glaucoma; patients in “Stage 0” had significantly lower costs than those in other groups (Kruskal–Wallis test, p < 0.01). This was a consequence of lower costs associated with medication and a lower percentage of patients undergoing surgery. The direct medical costs of a patient with primary open-angle glaucoma vary according to the severity of their disease and the year of treatment. We found that costs increased with disease severity, but decreased over time.
Fil: Real, Juan Pablo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica; Argentina
Fil: Lafuente, M. C.. Hospital Privado Centro Medico de Córdoba; Argentina
Fil: Palma, Santiago Daniel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica; Argentina
Fil: Tartara, Luis Ignacio. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica; Argentina
description o estimate the direct medical costs associated with the management of patients with primary open-angle glaucoma and to compare the costs of patients according to the degree of severity. A longitudinal retrospective study was carried out using all patients with primary open-angle glaucoma that recorded follow-up from May 2010 to June 2013 at the Hospital Privado de Córdoba. We estimated the cost of the disease from the perspectives of the institution, with a bottom-up approach. Results: The three-year follow-up after treatment of 104 patients revealed that the average cost of care for a patient with primary open-angle glaucoma was US$2746 ± 1560. The first year of treatment was significantly more expensive than subsequent ones (US$1100–$810–$827). Cost was related to the degree of severity of glaucoma; patients in “Stage 0” had significantly lower costs than those in other groups (Kruskal–Wallis test, p < 0.01). This was a consequence of lower costs associated with medication and a lower percentage of patients undergoing surgery. The direct medical costs of a patient with primary open-angle glaucoma vary according to the severity of their disease and the year of treatment. We found that costs increased with disease severity, but decreased over time.
publishDate 2018
dc.date.none.fl_str_mv 2018-09-04
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/91908
Real, Juan Pablo; Lafuente, M. C.; Palma, Santiago Daniel; Tartara, Luis Ignacio; Direct costs of glaucoma: Relationship between cost and severity of the disease; SAGE Publications Ltd; Chronic Illness; 4-9-2018; 1-9
1745-9206
1742-3953
CONICET Digital
CONICET
url http://hdl.handle.net/11336/91908
identifier_str_mv Real, Juan Pablo; Lafuente, M. C.; Palma, Santiago Daniel; Tartara, Luis Ignacio; Direct costs of glaucoma: Relationship between cost and severity of the disease; SAGE Publications Ltd; Chronic Illness; 4-9-2018; 1-9
1745-9206
1742-3953
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/http://journals.sagepub.com/doi/10.1177/1742395318803660
info:eu-repo/semantics/altIdentifier/doi/10.1177/1742395318803660
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
application/pdf
dc.publisher.none.fl_str_mv SAGE Publications Ltd
publisher.none.fl_str_mv SAGE Publications Ltd
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1846782383665184768
score 12.982451

Publicaciones similares